Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 13/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | PIM1 | P11309 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29852592 | 1.00 | ERN1 (1.00) | ERN1MEN1KMT2AMAPTPIM1 | |
| SCHEMBL6093685 | 0.84 | ERN1 (1.00) | ERN1PIM1ALDH1A1 | |
| SCHEMBL2553306 | 0.81 | ERN1 (0.68) | ERN1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL2553288 | 0.81 | ERN1 (0.68) | ERN1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL456670 | 0.78 | ERN1 (0.78) | ERN1PIM1 | |
| SCHEMBL29382880 | 0.78 | ERN1 (1.00) | ERN1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL29371317 | 0.78 | ERN1 (1.00) | ERN1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL30689082 | 0.78 | ERN1 (0.78) | ERN1PIM1 | |
| SCHEMBL9189245 | 0.78 | ERN1 (0.69) | ERN1PIM1 | |
| SCHEMBL2120180 | 0.78 | ERN1 (1.00) | ERN1MEN1KMT2AMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117820329-A | Spiropyran derivative and synthetic method and application thereof | 陕西科技大学 | 2024-04-05 | — | — | CN | claimed |
| CN-114113370-B | Analysis method of aromatic halogenated disinfection byproducts in water | 东南大学 | 2024-03-26 | — | — | CN | claimed |
| CN-115677530-B | Halogenated Schiff base Zn (II) complex Zn- χ -L and preparation method and application thereof | 昆明学院 | 2023-12-29 | — | — | CN | claimed |
| CN-117209741-A | Preparation method of Schiff base catalyst and preparation method of polyglycolic acid | 中国科学院长春应用化学研究所 | 2023-12-12 | — | — | CN | claimed |
| CN-115677530-A | Halogenated Schiff base Zn (II) complex Zn-chi-L and preparation method and application thereof | 昆明学院 | 2023-02-03 | — | — | CN | claimed |
| CN-114113370-A | Analysis method of aromatic halogenated disinfection byproducts in water | 东南大学 | 2022-03-01 | — | — | CN | claimed |
| CN-110981772-B | Methionine derived Schiff base copper complex and preparation and application thereof | 桂林医学院 | 2020-09-29 | — | — | CN | claimed |
| CN-110981772-A | Methionine derived Schiff base copper complex and preparation and application thereof | 桂林医学院 | 2020-04-10 | — | — | CN | claimed |
| US-10092786-B2 | Fire extinguishing composition comprising aldoketones compound | XI'AN WESTPEACE FIRE TECHNOLOGY CO., LTD. (CN) | 2018-10-09 | — | — | US | claimed |
| US-20160332016-A1 | Fire Extinguishing Composition Comprising Aldoketones Compound | NANO FIRE, LLC | 2016-11-17 | — | — | US | claimed |
| US-20260124309-A1 | STAT6 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260070932-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | ANNEXON INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12558341-B2 | Oral complement factor D inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| US-12509474-B2 | Inhibitors of complement factors and uses thereof | ANNEXON, INC. (US) | 2025-12-30 | — | — | US | disclosed |
| EP-4665339-A1 | INHIBITING ALPHA V BETA 8 INTEGRIN | Morphic Therapeutic, Inc. (US) | 2025-12-24 | — | — | EP | disclosed |
| EP-0850221-A1 | META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS | G.D. SEARLE & CO. (US) | 1998-07-01 | — | — | EP | disclosed |
| US-5710157-A | INSECTICIDES FOR AGRICULTURE | FMC CORPORATION (US) | 1998-01-20 | — | — | US | disclosed |
| WO-1997008145-A1 | META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS | G.D. SEARLE & CO. (US) | 1997-03-06 | — | — | WO | disclosed |
| US-5547954-A | MIXED WITH AGRICULTURAL ACCEPTABLE CARRIER | FMC CORPORATION (US) | 1996-08-20 | — | — | US | disclosed |
| US-5532370-A | FOR INSECTS INCLUDING LARVAE SUCH AS TOBACCO BUDWORM | FMC CORPORATION (US) | 1996-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124309-A1 | STAT6 DEGRADERS AND USES THEREOF | STAT6, NCOR2, NCOR1 | ERN1 1782/4885MEN1 4497/4885KMT2A 1231/4885 |
| US-12558341-B2 | Oral complement factor D inhibitors | CFD, CFH, CFB | ERN1 3303/4885MEN1 1819/4885KMT2A 4445/4885 |
| US-12509474-B2 | Inhibitors of complement factors and uses thereof | SSB, UACA, CFH | ERN1 912/4885MEN1 2996/4885KMT2A 4351/4885 |
| US-20260070932-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | CFH, CFB, C5 | ERN1 1448/4885MEN1 2993/4885KMT2A 4631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.